Patent Peer Review

The US Patent and Trademark Office is evaluating an online peer review initiative that would invite scientists and other outside experts to help evaluate patent applications by advising the PTO about prior art - published literature and other patents - that the patent office's examiners might otherwise overlook. The goal is to improve the quality of patent review and reduce the backlog of applications. "The patent office desperately needs more and better information to make decis

Written byTed Agres
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The US Patent and Trademark Office is evaluating an online peer review initiative that would invite scientists and other outside experts to help evaluate patent applications by advising the PTO about prior art - published literature and other patents - that the patent office's examiners might otherwise overlook. The goal is to improve the quality of patent review and reduce the backlog of applications. "The patent office desperately needs more and better information to make decisions" about patent applications, says Beth Simone Noveck, director of New York Law School's Institute for Information Law and Policy, which is working with the PTO to develop the project (http://dotank.nyls.edu/communitypatent/about.html).

If approved, the pilot will focus initially on computer software patents but could later be expanded to biotech and the life sciences. A decision on whether to proceed is expected sometime this year. "We are looking for representatives from the life sciences to provide ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies